Intrahepatic Mrna Expression of Interferon–Inducible Antiviral Genes in Liver Diseases: Dsrna–Dependent Protein Kinase Overexpression and Rnase L Inhibitor Suppression in Chronic Hepatitis C
Open Access
- 1 November 2000
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 32 (5) , 1089-1095
- https://doi.org/10.1053/jhep.2000.19287
Abstract
As a part of the defense mechanism of the host to viral infection, interferons induce the transcription of several genes. These interferon–inducible genes contribute to the eradication of the viruses. Whereas some studies suggested the participation of a dsRNA–dependent protein kinase in the host reaction to hepatitis C virus infection, the involvement of other interferon–inducible genes has not been evaluated. Furthermore, there has been no analysis on the expression profile of multiple interferon–inducible genes. The aim of this study was to clarify the hepatic mRNA expression profile of interferon–inducible genes with a special concern to chronic hepatitis C. A total of 76 liver biopsy samples (28 with chronic hepatitis C, 10 with chronic hepatitis B, 9 with alcoholic liver disease, 14 with autoimmune hepatitis, 10 with primary biliary cirrhosis, and 5 of normal liver) were enrolled. The expression of the following genes was quantified by competitive reverse transcription–polymerase chain reaction and was compared according to the etiology; dsRNA–dependent protein kinase (PKR), 2′,5′–oligoadenylate synthetase (2,5–AS), latent cellular endoribonuclease (RNase L), RNase L inhibitor, and MxA. As a result, PKR mRNA was significantly overexpressed in the liver of chronic hepatitis C compared with those of other etiologies (P= .0178), and it correlated significantly with serum alanine transaminase values (r = .51, P = .0054). Also, the expression of the RNase L inhibitor showed a significant reduction in chronic hepatitis C (P = .0184). The expressions of 2,5–AS, RNase L, and MxA were not different significantly irrespective to the etiology. In conclusion, hepatic overexpression of PKR and reduced expression of RNase L inhibitor seem to contribute to the anti–HCV mechanism characteristically.Keywords
This publication has 33 references indexed in Scilit:
- In Vivo and In Vitro Induction of MxA Protein in Peripheral Blood Mononuclear Cells from Patients Chronically Infected with Hepatitis C VirusThe Journal of Infectious Diseases, 1999
- Correlation of Interferon-Induced Expression of MxA mRNA in Peripheral Blood Mononuclear Cells with the Response of Patients with Chronic Active Hepatitis C to IFN-alpha TherapyJournal of Interferon & Cytokine Research, 1999
- Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase RegulationMolecular and Cellular Biology, 1998
- The MxA protein levels in whole blood lysates of patients with various viral infectionsJournal of Virological Methods, 1998
- Evidence That Hepatitis C Virus Resistance to Interferon Is Mediated through Repression of the PKR Protein Kinase by the Nonstructural 5A ProteinVirology, 1997
- Cloning and Characterization of a RNase L Inhibitor.Journal of Biological Chemistry, 1995
- Detection of interferon‐alpha expression by PCR in patients with chronic hepatitis C and hepatitis non‐A, non‐BJournal of Gastroenterology and Hepatology, 1994
- Changes of serum 2‘,5’‐oligoadenylate synthetase activity during interferon treatment of chronic hepatitis CLiver International, 1993
- The interferon system. A bird's eye view of its biochemistry.Published by Elsevier ,1992
- Detection of 2′,5′ oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stageGastroenterologia Japonica, 1991